Regulation of proteolipid protein (PLP) expression in oligodendrocytes cell lines of animal models for Pelizarus-Merzbacher Disease (PMP) using RNA interference (RNAi) technology
Summary
In this study, RNA interference technology was used to inhibit gene expression of the Proteolipid Protein (PLP) on Oligodendrocytes cell lines from Jimpy mutant mice, an animal model for Pelizaeus-Merzbacher Disease (PMD), which is a X-linked sever leukodystro...
In this study, RNA interference technology was used to inhibit gene expression of the Proteolipid Protein (PLP) on Oligodendrocytes cell lines from Jimpy mutant mice, an animal model for Pelizaeus-Merzbacher Disease (PMD), which is a X-linked sever leukodystrophy. The preliminary findings demonstrate a significant correction of functional aspects in oligodendrocytes, ie effect of dibutyryladenosine 3 ,5 - cyclic monophosphate (dbcAMP) application on both Myelin Basic Protein and Carbonic Anhydrase II expression. Our results suggest a breakthrough in leukodystrophy therapy especially if coupled with effective delivery system in vivo.
Keywords
Related Publications
Wathiq-SPU at AraSeg Shared Task 2026: Calibrated Transformer Ensembles for Arabic Sentence Segmentation across Punctuation and Paragraph Conditions
2026
Class-Balanced Hybrid Retrieval with Selective LLM Reranking
2026
SPU_DeepSimplify at the CLEF 2026 SimpleText Track: A Planning-Based Approach to Scientific Text Simplification
2026